NCT01333332Unknown2 期
Phase II Trial of Accelerated Fraction Radiotherapy With Concomitant Capecitabine as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- To determine the safety of neoadjuvant accelerated fraction standard dose radiotherapy to 50 Gy with concomitant capecitabine in patients with resectable and borderline resectable pancreas cancer.
研究概览
简要总结
The purpose of this study is to determine safety and to obtain preliminary estimates of the rate of major pathologic response of neoadjuvant accelerated fraction, standard dose radiation given with chemotherapy in patients with locally advanced pancreas cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Capecitabine, Radiation
Experimental
干预措施: Capecitabine (Drug)
Capecitabine, Radiation
Experimental
干预措施: Standard Dose Acclerated Fraction Radiotherapy (Radiation)
结局指标
主要结局
To determine the safety of neoadjuvant accelerated fraction standard dose radiotherapy to 50 Gy with concomitant capecitabine in patients with resectable and borderline resectable pancreas cancer.
时间窗: 2 years
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
2 期
Accelerated Fractionation Radiotherapy (AFRT) Versus Concurrent Chemoradiotherapy (Crt) In Locally Advanced Head And Neck Squamous Cell CarcinomaHEAD AND NECK CANCERNCT01291095All India Institute of Medical Sciences, New Delhi80
Unknown
1 期
Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate CancerProstate CancerNCT01505075Sunnybrook Health Sciences Centre30
已完成
1 期
Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate CancerProstate CancerNCT01146340Sunnybrook Health Sciences Centre30
终止
2 期
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHCIntrahepatic CholangiocarcinomaNCT02254681Allina Health System6
进行中（未招募）
1 期
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPCProstate CancerNCT04506567Weill Medical College of Cornell University60